WO2014096078A3 - Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine - Google Patents

Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine

Info

Publication number
WO2014096078A3
WO2014096078A3 PCT/EP2013/077206 EP2013077206W WO2014096078A3 WO 2014096078 A3 WO2014096078 A3 WO 2014096078A3 EP 2013077206 W EP2013077206 W EP 2013077206W WO 2014096078 A3 WO2014096078 A3 WO 2014096078A3
Authority
WO
WIPO (PCT)
Prior art keywords
agent
melanin
organisms
promotes
synthesis
Prior art date
Application number
PCT/EP2013/077206
Other languages
English (en)
Other versions
WO2014096078A2 (fr
Inventor
Lionel Breton
Audrey Gueniche
Michela ZUCCOLO
Annick Mercenier
Guénolé PRIOULT
Original Assignee
L'oreal
Nestec S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'oreal, Nestec S.A. filed Critical L'oreal
Priority to EP13808049.4A priority Critical patent/EP2934701A2/fr
Priority to US14/654,166 priority patent/US10456429B2/en
Priority to BR112015014725A priority patent/BR112015014725B8/pt
Publication of WO2014096078A2 publication Critical patent/WO2014096078A2/fr
Publication of WO2014096078A3 publication Critical patent/WO2014096078A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair

Abstract

La présente invention concerne l'utilisation, par voie topique, de Bifidobacterium longum subsp. longum CNCM I-2618, comme agent pro-pigmentant, notamment dans la prévention et/ou le traitement d'altérations de la couleur de la peau et/ou des cheveux et pour homogénéiser le teint.
PCT/EP2013/077206 2012-12-21 2013-12-18 Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine WO2014096078A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP13808049.4A EP2934701A2 (fr) 2012-12-21 2013-12-18 Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine
US14/654,166 US10456429B2 (en) 2012-12-21 2013-12-18 Use of probiotic micro-organisms as an agent that promotes the synthesis of melanin
BR112015014725A BR112015014725B8 (pt) 2012-12-21 2013-12-18 uso cosmético não terapêutico de pelo menos uma linhagem de micro-organismo e uso de uma linhagem de micro-organismo probiótico

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1262706 2012-12-21
FR1262706A FR2999933B1 (fr) 2012-12-21 2012-12-21 Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine

Publications (2)

Publication Number Publication Date
WO2014096078A2 WO2014096078A2 (fr) 2014-06-26
WO2014096078A3 true WO2014096078A3 (fr) 2014-11-13

Family

ID=48741232

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2013/077206 WO2014096078A2 (fr) 2012-12-21 2013-12-18 Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine

Country Status (5)

Country Link
US (1) US10456429B2 (fr)
EP (1) EP2934701A2 (fr)
BR (1) BR112015014725B8 (fr)
FR (2) FR2999933B1 (fr)
WO (1) WO2014096078A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3136374A1 (fr) 2022-06-09 2023-12-15 Inserm (Institut National De La Sante Et De La Recherche Medicale) Composition pour le traitement du vitiligo

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2916977A1 (fr) * 2007-06-06 2008-12-12 Engelhard Lyon Sa STIMULATION DE LA SYNTHESE DES RECPTEURS MCR1, MCR2 ET µ OPIOIDE.
FR2920306A1 (fr) * 2007-09-04 2009-03-06 Oreal Utilisation cosmetique d'un lysat de bifidobacterieum species.
EP2138186A1 (fr) * 2008-06-24 2009-12-30 Nestec S.A. Probiotiques, IgA de sécrétion et inflammation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1227152A1 (fr) * 2001-01-30 2002-07-31 Société des Produits Nestlé S.A. Souche bactérienne et genome de bifidobacterium
CA2761573A1 (fr) * 2009-05-11 2010-11-18 Nestec S.A. Bifidobacterium longum ncc2705 (cncm 1-2618) et troubles immunitaires

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2916977A1 (fr) * 2007-06-06 2008-12-12 Engelhard Lyon Sa STIMULATION DE LA SYNTHESE DES RECPTEURS MCR1, MCR2 ET µ OPIOIDE.
FR2920306A1 (fr) * 2007-09-04 2009-03-06 Oreal Utilisation cosmetique d'un lysat de bifidobacterieum species.
EP2138186A1 (fr) * 2008-06-24 2009-12-30 Nestec S.A. Probiotiques, IgA de sécrétion et inflammation

Also Published As

Publication number Publication date
EP2934701A2 (fr) 2015-10-28
FR2999933B1 (fr) 2020-01-31
FR2999933A1 (fr) 2014-06-27
US10456429B2 (en) 2019-10-29
US20150343002A1 (en) 2015-12-03
WO2014096078A2 (fr) 2014-06-26
BR112015014725B8 (pt) 2020-07-21
BR112015014725A2 (pt) 2017-07-11
BR112015014725B1 (pt) 2020-06-23
FR3050111A1 (fr) 2017-10-20

Similar Documents

Publication Publication Date Title
TN2012000611A1 (en) Formulations of rifaximin and uses thereof
TN2012000414A1 (en) Forms of rifaximin and uses thereof
ZA201304638B (en) Composition for use in the prevention and /or treatment of skin condition and skin diseases.
SG10201408166QA (en) Probiotic microorganisms as active agents for enhancing the radiance of the skin’s complexion
PL2928484T3 (pl) Związki przydatne w leczeniu lub pielęgnacji skóry, włosów lub błon śluzowych oraz ich kompozycji kosmetycznych lub farmaceutycznych
PT2149368T (pt) Utilização cosmética e dermatológica de microrganismos probióticos lactobacillus paracasei para o tratamento de distúrbios do couro cabeludo oleoso
PT2306970E (pt) Uso cosmético de lactobacillus paracasei para o tratamento de pele oleosa
WO2012030993A3 (fr) Compositions pour la peau et leurs applications
CA2863568A1 (fr) Utilisation topique d'un agent prebiotique commensal dermique et compositions le contenant
HK1169325A1 (en) Extract of whole seeds of moringa sp., and use thereof in cosmetic and or dermatological compositions
IN2012DN01920A (fr)
PL2758381T3 (pl) PREPARATY KOSMETYCZNE LUB DERMATOLOGICZNE ZAWIERAJĄCE AMIDOTIAZOLE ALKILOWE I ICH STOSOWANIE W CELU USUWANIA NIEPOŻĄDANYCH PRZEBARWIEŃ SKÓRY i ZAPOBIEGANIA ICH POWSTAWANIU
MX2018004616A (es) Cosmetica qie tiene bacterias probioticas.
WO2013139965A3 (fr) Exopolysaccharide dans le traitement et/ou le soin de la peau, des membranes muqueuses et/ou des ongles
EP2630949A4 (fr) Composition cosmétique, produit cosmétique pour les cheveux et produit cosmétique de traitement des cheveux
PL2758383T3 (pl) Preparaty kosmetyczne lub dermatologiczne zawierające amidotiazole aromatyczne i ich stosowanie do usuwania niepożądanych przebarwień skóry i zapobiegania ich powstawaniu
IN2014DN08921A (fr)
MY158310A (en) Prevention and treatment of allergic diarrhoea
EP2537513A3 (fr) Utilisation d'extrait d'Anogeissus pour la production de fibrilline dans la peau
PL2758382T3 (pl) Preparaty kosmetyczne lub dermatologiczne zawierające aminotiazole heterocyklokarbonylowe i ich stosowanie do usuwania niepożądanych przebarwień skóry i zapobiegania ich powstawaniu
EP2533752B8 (fr) Préparations pour stabiliser/élaborer la texture d'un tissu vivant comme la peau, et leurs applications
WO2014096083A3 (fr) Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine
WO2014096086A3 (fr) Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine
WO2014096078A3 (fr) Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine
WO2014096084A3 (fr) Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 14654166

Country of ref document: US

Ref document number: 2013808049

Country of ref document: EP

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112015014725

Country of ref document: BR

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13808049

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 112015014725

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20150619